FDA Approved: JORNAY PM EXTENDED-RELEASE — Original Application (Ironshore Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jornay PM Extended-Release (methylphenidate hydrochloride) under an original NDA by Ironshore Pharmaceuticals for the treatment of attention-defici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• JORNAY PM EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

ORIG AP for JORNAY PM EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)